Navigation Links
CaviWipes(R): Taking Surface Disinfection to a New Level
Date:3/3/2008

Unique design offers enhanced convenience, ease-of-use, and helps optimize

space

ORANGE, Calif., March 3 /PRNewswire/ -- Metrex Research Corporation is pleased to announce the newest member of its surface disinfection line, CaviWipes in a flat pack. Its unique patented design offers a new easy-open/easy-close pull tab with slim, flexible packaging and adhesive-backed strips. Each flat pack contains convenient, durable, nonwoven, nonabrasive disposable towelettes presaturated with CaviCide(R) surface disinfectant cleaner. CaviWipes in the new flat pack allows for easy placement of disinfectant wipes in areas with limited space, helping to maximize countertop and storage space.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080303/LAM047)

CaviWipes are recommended to clean and disinfect hard, nonporous surfaces in healthcare settings, such as hospitals, emergency medical settings, neonatal units, surgical centers, isolation areas, laboratories, patient care areas, dialysis centers, dental offices, emergency vehicles, police and fire vehicles, and other critical care areas where control of cross contamination between treated surfaces is required. CaviWipes are tuberculocidal, bactericidal, virucidal and fungicidal. They are proven to kill TB in 3 minutes, and Methicillin-Resistant Staphylococcus aureus (MRSA), HIV-1, Hepatitis B virus, and Hepatitis C virus in 2 minutes.

Over the past few years, an alarming increase of infections resulting from drug-resistant microorganisms has been reported in healthcare settings, schools, and other public facilities around the nation. This trend has elevated the need for surface disinfection products that are proven to kill these challenging microorganisms effectively.

Patients and healthcare workers alike are looking to manufacturers, such as Metrex, to provide solutions that help
'/>"/>

SOURCE Metrex Research Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes
2. Arthrosurface Raises $4 Million of Preferred Equity Financing
3. Harland Medical Systems to Offer March Plasma Systems Surface Materials
4. Surface Logix Achieves Objectives With SLx-4090 in Phase 2a Clinical Trial
5. Decision Biomarkers Awarded U.S. Patent for Protein Array Surface Chemistry
6. Sureshield Coatings Company Established to Market Industry-Leading Portfolio of Advanced Coatings for Metal Surfaces
7. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
8. Physicists pin down spin of surface atoms
9. Nasal Vaccine for Smallpox Confers High Levels of Immunity Without Safety Risks
10. Chemists measure copper levels in zinc oxide nanowires
11. Phase 1 Studies Show Promise of QuatRxs Novel Compound, Sobetirome, for Lowering LDL Cholesterol Levels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... United Kingdom, Dec. 10 Newly ... East England Stem Cell Institute (NESCI) in ... successful treatment of eight patients with "Limbal ... own stem cells without the need of ... http://www.newscom.com/cgi-bin/prnh/20080422/CLTU133LOGO-a ) ,, LSCD is a painful, ...
(Date:12/10/2009)... Dec. 10 /PRNewswire-Asia-FirstCall/ -- China Biologic,Products, Inc. (Nasdaq: ... one of the,leading plasma-based biopharmaceutical companies in China, ... ring the opening bell at the,NASDAQ MarketSite in ... Tuesday, December 15,2009. , ... NASDAQ Global Market on,December 2, 2009, under the ...
(Date:12/10/2009)... Biomatrica, the leader in room temperature ... SampleWare 3.1 software system for laboratory inventory, organization ... now includes an audit trail functionality that tracks ... complete history of any stored sample. ,, ... customers a much needed ability to track all ...
(Date:12/10/2009)... to Create Optimized Antibodies Produces First Candidates ... , MISSISSAUGA, ON, Dec. 10 /PRNewswire-FirstCall/ - ... announced the first results of a collaborative ... Research Council of Canada,s Biotechnology Research ... program is designed to generate novel antibodies ...
Breaking Biology Technology:Successful Stem Cell Therapy for Treatment of Eye Disease 2Successful Stem Cell Therapy for Treatment of Eye Disease 3Successful Stem Cell Therapy for Treatment of Eye Disease 4China Biologic Products to Ring NASDAQ Opening Bell 2China Biologic Products to Ring NASDAQ Opening Bell 3Biomatrica Launches SampleWare 3.1 2Biomatrica Launches SampleWare 3.1 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5
... (Nasdaq:,CPHD) today announced the appointment of leading ... Fred Tenover, Ph.D., as,Senior Director of Scientific ... liaison,with the Infection Control community and will ... "The objective of the Cepheid HAI ...
... 9 Par,Pharmaceutical Companies, Inc. (NYSE: PRX ) ... 25mg meclizine HCl tablets immediately. At,this time, Par believes ... Par marketed meclizine prior to an explosion at ... has since qualified a new API source and,received the ...
... YARDLEY, Pa. and WOBURN, Mass., July 9 ... Business, Technology and,Regulatory strategies, and CBI Research Inc., ... executives in the pharmaceutical,and biotech industries, today announced ... will chair CBI,s "3rd Annual Manufacturing Execution,Systems for ...
Other Biology Technology:Noted Molecular Epidemiologist Joins Cepheid to Head Healthcare Associated Infection Consortium Program 2Noted Molecular Epidemiologist Joins Cepheid to Head Healthcare Associated Infection Consortium Program 3Par Pharmaceutical to Launch meclizine HCL Tablets 2Axendia's President to Chair 3rd Annual MES for Life Sciences Congress 2
(Date:12/14/2009)... researchers from the Astrobiology Centre (INTA-CSIC) has shown that ... the formation of the most basic biological molecules can ... to carry out this study, published in the journal ... chemical conditions of the early Earth. , "We have ... solutions it produces hydrogen cyanide, a substance that could ...
(Date:12/14/2009)... WAYNE, Pa., Dec. 14 MODA Technology ... monitoring (EM), utility and product testing for the ... MODA 3.0, the company,s third generation mobile data ... (QC) organizations to further automate their regulated manufacturing ... new capabilities: ,, Fully-Configurable Test Methods: ...
(Date:12/13/2009)... Scientists have resolved a question about how a ... works using biosensors that reveal previously hidden components ... Although delusions and hallucinations characterize the illness, people ... recall information in a particular order, difficulties that ... or function well, said Lee Schroeder, a student ...
Breaking Biology News(10 mins):Prussian blue linked to the origin of life 2MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2New biosensors reveal workings of anti-psychotic drugs in the living brain 2Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 62361 1Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 62361 2Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 62361 3Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 62361 4Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 62361 5Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 15027 1Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 15027 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 15027 3Neogen Acquires Gen Probes BioKits Food Safety Business 6639 1Neogen Acquires Gen Probes BioKits Food Safety Business 6639 2
... stand-in for humans in medical research, thanks to genomes ... behave differently in mouse and man, a study by ... Zhang reveals. , Their results, which have implications for ... appear in the current issue of the journal Proceedings ...
... Studying thousands of patients, Japanese researchers have found ... of three cancers esophageal, head and neck, and ... risk of developing these diseases. , In the May ... of the American Association for Cancer Research, scientists from ...
... bioMETRX, Inc. (OTC,Bulletin Board: BMRX) a leading developer ... has filed 5 new patent applications with,the United ... covered by the filings include tool storage chests, ... The,traditional products that are the subject of the ...
Other Biology News:Mouse can do without man's most treasured genes 2Mouse can do without man's most treasured genes 3Tooth loss strongly linked to risk of esophageal, head and neck, and lung cancer 2bioMETRX, Inc. Files for Several New Patents 2